Effectiveness and safety of chest pain assessment to prevent emergency admissions: ESCAPE cluster randomised trial

胸痛评估预防急诊入院的有效性和安全性:ESCAPE 整群随机试验

阅读:3

Abstract

OBJECTIVE: To determine whether introducing chest pain unit care reduces emergency admissions without increasing reattendances and admissions over the next 30 days. DESIGN: Cluster randomised before and after intervention trial. SETTING: 14 diverse acute hospitals in the United Kingdom. PARTICIPANTS: Patients attending the emergency department with acute chest pain during the year before and the year after the intervention started. INTERVENTION: Establishment of chest pain unit care compared with continuation of routine care. MAIN OUTCOME MEASURES: Proportion of chest pain attendances resulting in admission; reattendances and admissions over the next 30 days; daily emergency medical admissions (all causes); and proportion of emergency department attendances with chest pain. RESULTS: The introduction of chest pain unit care was associated with weak evidence of an increase in emergency department attendances with chest pain (16% v 3.5%; P=0.08); no change in the proportion of chest pain attendances resulting in admission (odds ratio 0.998, 95% confidence interval 0.940 to 1.059; P=0.945); small increases in the proportion reattending (odds ratio 1.10, 1.00 to 1.21; P=0.036) or being admitted (1.30, 0.97 to 1.74; P=0.083) over the next 30 days; and evidence of increased daily medical admissions (1.7 per day, 95% confidence interval 0.8 to 2.5; P<0.001). However, this last finding was highly sensitive to changes in the method used to handle missing data. CONCLUSION: The introduction of chest pain unit care did not reduce the proportion of patients with chest pain admitted and may have been associated with increased emergency department attendances with chest pain. TRIAL REGISTRATION: Current Controlled Trials ISRCTN55318418.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。